Meta Information
ID:omega-3-epa-dha
Name:
Schema Version:AIM-2.0
Created
2026-05-10T18:48:18.503789Z
Model
Gemini 3.1 Pro (High)
Interactions
Target id:
/class/anticoagulants-antiplatelets
Target name:
Anticoagulants and Antiplatelets
Severity:
major
Interaction type:
adverse
Nature:
absolute
Description:
Significantly increases the risk of serious bleeding by compounding the blood-thinning effects of these medications.
Actionable advice:
Requires close medical supervision.
Target id:
/intervention/icosapent-ethyl
Target name:
Icosapent Ethyl
Severity:
major
Interaction type:
adverse
Nature:
absolute
Description:
This is a prescription omega-3; taking more can increase risks like bleeding or atrial fibrillation.
Actionable advice:
Do not combine without medical direction.
Target id:
/class/nsaids
Target name:
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Description:
Increases the risk of gastrointestinal bleeding and bruising due to combined antiplatelet (blood-thinning) effects.
Actionable advice:
Use combination with caution.
Target id:
/intervention/fibrates
Target name:
Fibrates
Severity:
moderate
Interaction type:
synergistic
Nature:
absolute
Description:
Both significantly lower triglycerides; their combined use can be highly effective for managing hypertriglyceridemia.
Actionable advice:
Requires medical supervision and monitoring.
Target id:
/intervention/bile-acid-sequestrants
Target name:
Bile Acid Sequestrants
Severity:
moderate
Interaction type:
diminishing
Nature:
absolute
Description:
May bind to omega-3s in the gut, reducing their absorption and overall effectiveness.
Actionable advice:
Separate doses by at least 4 hours.
Target id:
/intervention/statins
Target name:
Statins
Severity:
moderate
Interaction type:
synergistic
Nature:
absolute
Description:
Often used together to improve the overall lipid profile, lowering both triglycerides and LDL cholesterol.
Actionable advice:
Monitor lipid panel as directed.
Target id:
/class/herbal-anticoagulants
Target name:
Herbal Anticoagulants/Antiplatelets
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Description:
Combining with other herbal blood-thinners increases the risk of bruising or more serious bleeding events.
Actionable advice:
Avoid combining multiple blood-thinning supplements.
Target id:
/intervention/ezetimibe
Target name:
Ezetimibe
Severity:
moderate
Interaction type:
synergistic
Nature:
absolute
Description:
Works with ezetimibe to further lower triglyceride levels, which is often a therapeutic goal.
Actionable advice:
Monitor lipid panel as directed.
Target id:
/intervention/vitamin-e
Target name:
Vitamin E
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Description:
Both have mild blood-thinning properties, which could slightly increase the risk of bruising or bleeding.
Actionable advice:
Use caution with high doses.
Target id:
/class/antihypertensives
Target name:
Antihypertensive Medications
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Description:
May enhance the blood pressure-lowering effects of these medications, potentially causing dizziness or lightheadedness.
Actionable advice:
Monitor blood pressure regularly.
Target id:
/class/antidiabetic-medications
Target name:
Diabetes Medications
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Description:
High doses may slightly affect blood sugar levels, requiring monitoring in those on diabetes medication.
Actionable advice:
Monitor blood glucose levels.